Women’s Digital Health Market (By Type: Mobile Apps, Wearable Devices, Diagnostic Tools, Others; By Application: Reproductive Health, Pregnancy & Nursing Care, Pelvic Care, General Healthcare & Wellness) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Women’s Digital Health Market, By Type

7.1.  Women’s Digital Health Market, By Type, 2020-2030

7.1.1.    Mobile Apps

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Wearable Devices

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Diagnostic Tools

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Women’s Digital Health Market, By Application

8.1.  Women’s Digital Health Market, by Application, 2020-2030

8.1.1.    Reproductive Health

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Pregnancy & Nursing Care

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Pelvic Care

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    General Healthcare & Wellness

8.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Women’s Digital Health Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Type (2016-2030)

9.1.2.    Market Revenue and Forecast, by Application (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Type (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Type (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Type (2016-2030)

9.2.2.    Market Revenue and Forecast, by Application (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Type (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Type (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Type (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Type (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Type (2016-2030)

9.3.2.    Market Revenue and Forecast, by Application (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Type (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Type (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Type (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Type (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Type (2016-2030)

9.4.2.    Market Revenue and Forecast, by Application (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Type (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Type (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Type (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Type (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by Application (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Type (2016-2030)

9.5.2.    Market Revenue and Forecast, by Application (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Type (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Type (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by Application (2016-2030)

Chapter 10.  Company Profiles

10.1.              HeraMED

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              iSono Health

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Clue by Biowink

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Chiaro Technology Ltd.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Natural Cycles

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Ava Science, Inc.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              NURX Inc.

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Prima-Temp, Inc.

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Glow

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Lucina Health

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           MobileODT Ltd.

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

10.12.           Braster SA

10.12.1.               Company Overview

10.12.2.               Product Offerings

10.12.3.               Financial Performance

10.12.4.               Recent Initiatives

10.13.           Athena Feminine Technologies

10.13.1.               Company Overview

10.13.2.               Product Offerings

10.13.3.               Financial Performance

10.13.4.               Recent Initiatives

10.14.           Plackal Tech

10.14.1.               Company Overview

10.14.2.               Product Offerings

10.14.3.               Financial Performance

10.14.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms